Free Trial

bioMérieux (BMXMF) News Today

bioMérieux logo
$102.39 -4.62 (-4.32%)
(As of 11/20/2024 ET)
bioMérieux S.A. stock logo
bioMérieux (OTCMKTS:BMXMF) Stock Crosses Below Fifty Day Moving Average - What's Next?
bioMérieux (OTCMKTS:BMXMF) Stock Price Crosses Below 50 Day Moving Average - Here's What Happened
bioMérieux S.A. stock logo
bioMérieux S.A. (OTCMKTS:BMXMF) Short Interest Down 20.2% in October
bioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) was the target of a significant decline in short interest during the month of October. As of October 15th, there was short interest totalling 128,700 shares, a decline of 20.2% from the September 30th total of 161,300 shares. Based on an average trading volume of 5,000 shares, the days-to-cover ratio is presently 25.7 days.
bioMérieux S.A. stock logo
bioMérieux (OTCMKTS:BMXMF) Stock Crosses Below 50 Day Moving Average - Time to Sell?
bioMérieux (OTCMKTS:BMXMF) Share Price Crosses Below 50 Day Moving Average - Time to Sell?
bioMérieux S.A. stock logo
Short Interest in bioMérieux S.A. (OTCMKTS:BMXMF) Drops By 26.8%
bioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) saw a significant decline in short interest in September. As of September 15th, there was short interest totalling 165,200 shares, a decline of 26.8% from the August 31st total of 225,800 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 1,652.0 days.
bioMérieux S.A. (BMXMF)
bioMérieux S.A. stock logo
bioMérieux (OTCMKTS:BMXMF) Hits New 12-Month High at $122.52
bioMérieux (OTCMKTS:BMXMF) Reaches New 12-Month High at $122.52
Berenberg Bank Keeps Their Buy Rating on bioMerieux (0RUG)
Kepler Capital Reaffirms Their Buy Rating on bioMerieux (0RUG)
bioMérieux S.A. stock logo
bioMérieux (OTCMKTS:BMXMF) Hits New 12-Month High at $120.00
bioMérieux (OTCMKTS:BMXMF) Sets New 52-Week High at $120.00
bioMérieux S.A. stock logo
bioMérieux (OTCMKTS:BMXMF) Hits New 52-Week High at $119.62
bioMérieux (OTCMKTS:BMXMF) Reaches New 52-Week High at $119.62
bioMerieux (0RUG) Gets a Buy from Kepler Capital
bioMérieux S.A. stock logo
UBS Group Upgrades bioMérieux (OTCMKTS:BMXMF) to "Strong-Buy"
UBS Group upgraded shares of bioMérieux to a "strong-buy" rating in a research note on Thursday.
Baxter International Inc. (BAX)
BioMerieux SA BIM
BMXMF bioMérieux S.A.
Biomerieux/adr's Net Worth
bioMerieux : du mieux
bioMerieux recule après les annonces
Get bioMérieux News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMXMF and its competitors with MarketBeat's FREE daily newsletter.

2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)

The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.

👉[Click here to get your FREE report delivered instantly!]

BMXMF Media Mentions By Week

BMXMF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BMXMF
News Sentiment

0.00

0.46

Average
Medical
News Sentiment

BMXMF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BMXMF Articles
This Week

0

0

BMXMF Articles
Average Week

Get bioMérieux News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMXMF and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (OTCMKTS:BMXMF) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners